Research and Grants | The Cure Starts Now

The Cure Starts Now has funded $18,897,055 in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 119 grants at over 100 hospitals in 17 countries.


Ann & Robert H. Lurie Children's Hospital - $100,000

Amount
$100,000.00
Date
October 2017

Determine the efficacy of BMP and MEK inhibitors with RT to treat ACVR1 mutant DIPG

Anschutz Medical Campus - $50,000

Amount
$50,000.00
Date
September 2017

Toward a Multimodality Cure for DIPG: Investigation of Intratumoral Drug Penetration and Craniospinal Irradiation.

Massachusetts General Hospital - $50,000

Amount
$50,000.00
Date
September 2017

Repurposing Mefloquine for Diffuse Intrinsic Pontine Glioma Therapy

CONNECT Consortium - $899,518.80

Amount
$899,518.00
Date
September 2017

CONNECT (COllaborative Network for NEurooncology Clinical Trials) Consortium

University of Massachusetts Medical School - $50,000

Amount
$50,000.00
Date
May 2017

Advanced RNAi therapeutics for DIPG

Lucile Packard Children's Hospital Stanford - $50,000

Amount
$50,000.00
Date
May 2017

Cellular Cybercriminals: DIPG Hacks into the Neural Communication Infrastructure

Hospital for Sick Children - $50,000

Amount
$50,000.00
Date
September 2016

MRI Guided Focused Ultrasound: Targeted Drug Delivery in Diffuse Intrinsic Pontine Glioma

Gustave Roussy Cancer Center - $93,071

Amount
$93,071.00
Date
September 2016

Ultrasound-induced delivery of Panobinostat in preclinical models